SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-062072
Filing Date
2022-12-19
Accepted
2022-12-19 21:22:00
Documents
2
Period of Report
2022-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1553
2 POA DOCUMENT poa.txt EX-24 3032
  Complete submission text file 0001209191-22-062072.txt   5963
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RENEO PHARMACEUTICALS, INC. 12230 EL CAMINO REAL, SUITE 230 SAN DIEGO CA 92130
Business Address
Cardon Lon (Reporting) CIK: 0001854337 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38981 | Film No.: 221472724